Abstract
Developments in "-omics" are creating a paradigm shift in laboratory medicine leading to personalized medicine. This allows the increase in diagnostics and therapeutics focused on individuals rather than populations. In order to investigate whether laboratory medicine is ready to play a key role in the integration of personalized medicine in routine health care and set the state-of-the-art knowledge about personalized medicine and laboratory medicine in Europe, a questionnaire was constructed under the auspices of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) and the European Society of Pharmacogenomics and Personalised Therapy (ESPT). The answers of the participating laboratory medicine professionals indicate that they are aware that personalized medicine can represent a new and promising health model, and that laboratory medicine should play a key role in supporting the implementation of personalized medicine in the clinical setting. Participants think that the current organization of laboratory medicine needs additional/relevant implementations such as (i) new technological facilities in -omics; (ii) additional training for the current personnel focused on the new methodologies; (iii) incorporation in the laboratory of new competencies in data interpretation and counseling; and (iv) cooperation and collaboration among professionals of different disciplines to integrate information according to a personalized medicine approach.
| Original language | English |
|---|---|
| Pages (from-to) | 121-128 |
| Number of pages | 8 |
| Journal | Drug Metabolism and Personalized Therapy |
| Volume | 30 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - Jun 1 2015 |
Fingerprint
Keywords
- "-omics" technologies
- laboratory medicine
- personalized medicine
ASJC Scopus subject areas
- Pharmacology (medical)
- Pharmacology, Toxicology and Pharmaceutics(all)
Cite this
Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe. / Malentacchi, Francesca; Mancini, Irene; Brandslund, Ivan; Vermeersch, Pieter; Schwab, Matthias; Marc, Janja; Van Schaik, Ron H N; Siest, Gerard; Theodorsson, Elvar; Pazzagli, Mario; Di Resta, Chiara; European Federation of Clinical Chemistry, Federation of Clinical Chemistry; European Society of Pharmacogenomics, Society of Pharmacogenomics.
In: Drug Metabolism and Personalized Therapy, Vol. 30, No. 2, 01.06.2015, p. 121-128.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe
AU - Malentacchi, Francesca
AU - Mancini, Irene
AU - Brandslund, Ivan
AU - Vermeersch, Pieter
AU - Schwab, Matthias
AU - Marc, Janja
AU - Van Schaik, Ron H N
AU - Siest, Gerard
AU - Theodorsson, Elvar
AU - Pazzagli, Mario
AU - Di Resta, Chiara
AU - European Federation of Clinical Chemistry, Federation of Clinical Chemistry
AU - European Society of Pharmacogenomics, Society of Pharmacogenomics
PY - 2015/6/1
Y1 - 2015/6/1
N2 - Developments in "-omics" are creating a paradigm shift in laboratory medicine leading to personalized medicine. This allows the increase in diagnostics and therapeutics focused on individuals rather than populations. In order to investigate whether laboratory medicine is ready to play a key role in the integration of personalized medicine in routine health care and set the state-of-the-art knowledge about personalized medicine and laboratory medicine in Europe, a questionnaire was constructed under the auspices of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) and the European Society of Pharmacogenomics and Personalised Therapy (ESPT). The answers of the participating laboratory medicine professionals indicate that they are aware that personalized medicine can represent a new and promising health model, and that laboratory medicine should play a key role in supporting the implementation of personalized medicine in the clinical setting. Participants think that the current organization of laboratory medicine needs additional/relevant implementations such as (i) new technological facilities in -omics; (ii) additional training for the current personnel focused on the new methodologies; (iii) incorporation in the laboratory of new competencies in data interpretation and counseling; and (iv) cooperation and collaboration among professionals of different disciplines to integrate information according to a personalized medicine approach.
AB - Developments in "-omics" are creating a paradigm shift in laboratory medicine leading to personalized medicine. This allows the increase in diagnostics and therapeutics focused on individuals rather than populations. In order to investigate whether laboratory medicine is ready to play a key role in the integration of personalized medicine in routine health care and set the state-of-the-art knowledge about personalized medicine and laboratory medicine in Europe, a questionnaire was constructed under the auspices of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) and the European Society of Pharmacogenomics and Personalised Therapy (ESPT). The answers of the participating laboratory medicine professionals indicate that they are aware that personalized medicine can represent a new and promising health model, and that laboratory medicine should play a key role in supporting the implementation of personalized medicine in the clinical setting. Participants think that the current organization of laboratory medicine needs additional/relevant implementations such as (i) new technological facilities in -omics; (ii) additional training for the current personnel focused on the new methodologies; (iii) incorporation in the laboratory of new competencies in data interpretation and counseling; and (iv) cooperation and collaboration among professionals of different disciplines to integrate information according to a personalized medicine approach.
KW - "-omics" technologies
KW - laboratory medicine
KW - personalized medicine
UR - http://www.scopus.com/inward/record.url?scp=84930971839&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84930971839&partnerID=8YFLogxK
U2 - 10.1515/dmdi-2015-0012
DO - 10.1515/dmdi-2015-0012
M3 - Article
C2 - 26036226
AN - SCOPUS:84930971839
VL - 30
SP - 121
EP - 128
JO - Drug Metabolism and Personalized Therapy
JF - Drug Metabolism and Personalized Therapy
SN - 2363-8907
IS - 2
ER -